Elysium Therapeutics (United States)

Recent papers from Elysium Therapeutics (United States)

1. A Governance-Aware Framework for Post-Quantum Migration in Digital Financial Infrastructure2025
2. Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trialFrontiers in Aging · 2026
3. Impaired fetal brain growth and neurodevelopmental deficits at 2 years: deep phenotyping of maternal–fetal pathophysiologyThe Lancet Obstetrics Gynaecology & Women s Health · 2026
4. Practical Considerations for Post-Quantum Cryptographic Migration in Financial Systems2025
5. Pathogen-specific host response in critically ill patients with blood stream infections: a nested case–control studyEBioMedicine · 2025
6. Low cholesterol and risk of violence in forensic inpatients with schizophrenia, personality disorder or dual diagnosis: same or different?European Psychiatry · 2025
7. Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trialNature Aging · 2024
8. Inhibition of UVB radiation‐induced tissue swelling and immune suppression by nicotinamide riboside and pterostilbenePhotodermatology Photoimmunology & Photomedicine · 2024
9. Combination of natural polyphenols with a precursor of NAD+ and a TLR2/6 ligand lipopeptide protects mice against lethal γ radiationJournal of Advanced Research · 2022
10. Intravenous nicotinamide riboside elevates mouse skeletal muscle NAD+ without impacting respiratory capacity or insulin sensitivityiScience · 2022
11. Gene Expression Profiles in Sporadic ALS Fibroblasts Define Disease Subtypes and The Metabolic Effects of the Investigational Drug EH3012021
12. A randomized placebo-controlled clinical trial of Nicotinamide Riboside and Pterostilbene supplementation in experimental muscle injury in elderly subjects2021
13. NAD+ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral SclerosisBiomedicines · 2021
14. A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking2021
15. Pterostilbene in Cancer TherapyAntioxidants · 2021
16. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot studyAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2019
17. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled studynpj Aging and Mechanisms of Disease · 2017
18. Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus BioefficacyJournal of Medicinal Chemistry · 2017